BlackRock Fund Advisors - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 20 filers reported holding HISTOGENICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q4 2016$4,000
-33.3%
2,489
+27.7%
0.00%
Q3 2016$6,000
-57.1%
1,949
-75.9%
0.00%
Q2 2016$14,000
-61.1%
8,073
-49.3%
0.00%
Q1 2016$36,000
-40.0%
15,938
-6.4%
0.00%
Q4 2015$60,000
-4.8%
17,030
+6.9%
0.00%
Q3 2015$63,000
-40.6%
15,928
-2.6%
0.00%
Q2 2015$106,000
+19.1%
16,348
+84.2%
0.00%
Q1 2015$89,0008,8740.00%
Other shareholders
HISTOGENICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Sofinnova Management VIII, L.L.C. 2,077,040$3,469,0001.95%
Abingworth LLP 888,889$1,440,0001.20%
ARMISTICE CAPITAL, LLC 1,264,000$2,111,0000.50%
Third Security, LLC 2,690,570$4,493,0000.24%
Perceptive Advisors 1,777,777$2,968,0000.21%
CARL DOMINO INC 87,000$145,0000.16%
SABBY MANAGEMENT, LLC 944,891$1,578,0000.09%
Palo Alto Investors LP 302,922$506,0000.03%
PURA VIDA INVESTMENTS, LLC 13,526$23,0000.01%
Virtu KCG Holdings LLC 14,764$25,0000.00%
View complete list of HISTOGENICS CORP shareholders